Skip Navigation

Reports of Patent, Design and Trade Mark Cases 2005 122(6):169-207; doi:10.1093/rpc/2005rpc9
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add to My Personal Archive
Right arrowRequest Permissions
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Crown Copyright

[2005] R.P.C. 9

KIRIN-AMGEN INC v HOECHST MARION ROUSSEL LTD

House of Lords

(Lord Hoffman, Lord Hope of Craighead, Lord Rodger of Earlsferry, Lord Walker of Gestingthorpe and Lord Brown of Eaton-under-Heywood): October 21, 20041

[2004] UKHL 46; [2005] R.P.C. 9

Patent—Infringement—Erythropoietin—Recombinant DNA technology—Construction of claims—Principles of construction—Role of Protocol questions—Importance of identifying the invention—Whether claims covered technology unknown at date of patent—Novelty—Product-by-process claims—Whether permissible—Insufficiency—Breadth of claims—Principle of general application—Disclosure must be both necessary and sufficient—Inability to establish infringement of unclear claim—Claim invalid for insufficiency and not mere lack of clarity—Observations on use of court expert to instruct court in technology.

Key Words: Declarations of non-infringement • Insufficiency • Interpretation • Novelty • Patents • Pharmaceuticals • Revocation


1 Paragraph numbers in this judgment are as assigned by the court.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.